Evidence Synthesis
Vasuprada reported a quarterly gross margin of 78.18%, accelerating from -2.32% in the previous quarter.
The company's marginal operating leverage also showed an acceleration, rising to from -4.96%. Vasuprada's revenue growth year-over-year was negative at , while its daily volume declined to from 178 shares. The close price remained unchanged at .